Anders Grubb

27.5k total citations · 5 hit papers
340 papers, 19.9k citations indexed

About

Anders Grubb is a scholar working on Molecular Biology, Nephrology and Physiology. According to data from OpenAlex, Anders Grubb has authored 340 papers receiving a total of 19.9k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Molecular Biology, 99 papers in Nephrology and 51 papers in Physiology. Recurrent topics in Anders Grubb's work include Chronic Kidney Disease and Diabetes (90 papers), Dialysis and Renal Disease Management (64 papers) and Protease and Inhibitor Mechanisms (42 papers). Anders Grubb is often cited by papers focused on Chronic Kidney Disease and Diabetes (90 papers), Dialysis and Renal Disease Management (64 papers) and Protease and Inhibitor Mechanisms (42 papers). Anders Grubb collaborates with scholars based in Sweden, United States and Poland. Anders Grubb's co-authors include Magnus Abrahamson, Veronica Lindström, Helge Löfberg, Ísleifur Ólafsson, Jonas Björk, A. John Barrett, Hans Thysell, Ulf Nyman, Gunnar Sterner and Mariusz Jaskólski and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Anders Grubb

333 papers receiving 19.3k citations

Hit Papers

Cystatin C as a marker of GFR—history, indicati... 1986 2026 1999 2012 2004 1995 1986 1994 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cystatin C as a marker of GFR—history, indications, and future research
    2004 541 citations Arend Bökenkamp, Anders Grubb et al. profile →
  2. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine
    1995 524 citations Anders Grubb et al. Kidney International profile →
  3. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids.
    1986 439 citations Magnus Abrahamson, Anders Grubb et al. profile →
  4. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate
    1994 422 citations Veronica Lindström, Anders Grubb et al. profile →
  5. Measuring GFR: A Systematic Review
    2014 352 citations Ulla Berg, Jonas Björk et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Grubb Sweden 74 7.2k 4.5k 3.2k 2.3k 2.0k 340 19.9k
Kiyoshi Kurokawa Japan 75 8.3k 1.2× 5.2k 1.2× 2.7k 0.8× 796 0.4× 2.3k 1.2× 522 22.6k
Jeffrey B. Kopp United States 88 10.8k 1.5× 8.6k 1.9× 3.1k 1.0× 1.3k 0.6× 2.2k 1.1× 377 25.3k
Hirofumi Makino Japan 74 6.6k 0.9× 7.0k 1.5× 2.7k 0.8× 1.2k 0.5× 2.6k 1.3× 672 23.6k
Alberto Ortíz Spain 85 9.8k 1.4× 8.7k 1.9× 4.3k 1.3× 2.3k 1.0× 3.1k 1.6× 847 28.9k
Ariela Benigni Italy 77 5.6k 0.8× 5.8k 1.3× 2.9k 0.9× 920 0.4× 2.0k 1.0× 335 18.9k
Kerstin Amann Germany 74 7.5k 1.0× 6.7k 1.5× 2.1k 0.6× 1.5k 0.7× 3.3k 1.7× 584 24.4k
Masaomi Nangaku Japan 82 8.4k 1.2× 6.9k 1.5× 2.0k 0.6× 3.1k 1.4× 2.3k 1.2× 712 24.1k
Harry van Goor Netherlands 73 3.6k 0.5× 5.3k 1.2× 2.2k 0.7× 747 0.3× 2.8k 1.4× 626 27.0k
Marta Ruiz‐Ortega Spain 70 4.7k 0.7× 6.9k 1.5× 1.6k 0.5× 1.6k 0.7× 1.8k 0.9× 265 18.2k
Ton J. Rabelink Netherlands 81 3.9k 0.5× 7.1k 1.6× 5.1k 1.6× 1.7k 0.8× 3.2k 1.6× 542 25.9k

Countries citing papers authored by Anders Grubb

Since Specialization
Citations

This map shows the geographic impact of Anders Grubb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Grubb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Grubb more than expected).

Fields of papers citing papers by Anders Grubb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Grubb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Grubb. The network helps show where Anders Grubb may publish in the future.

Co-authorship network of co-authors of Anders Grubb

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Grubb. A scholar is included among the top collaborators of Anders Grubb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Grubb. Anders Grubb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grubb, Anders, Shahab Nozohoor, Igor Zindovic, et al.. (2025). Shrunken pore syndrome in heart transplantation: a pore ready to close?. Scandinavian Cardiovascular Journal. 59(1). 2481173–2481173.
2.
Delanaye, Pierre, Jonas Björk, Emmanuelle Vidal‐Petiot, et al.. (2024). Diabetic status and the performances of creatinine- and cystatin C–based eGFR equations. Nephrology Dialysis Transplantation. 40(3). 516–523. 4 indexed citations
3.
Åkesson, Anna, Linnea Malmgren, Ulf Nyman, et al.. (2024). Different ways of diagnosing selective glomerular hypofiltration syndromes such as shrunken pore syndrome and the associated increase in mortality. Journal of Internal Medicine. 297(1). 79–92. 4 indexed citations
4.
Tighiouart, Hocine, Shiyuan Miao, Marc Froissart, et al.. (2024). Estimating glomerular filtration rate in kidney transplant recipients: considerations for selecting equations. Kidney International. 106(5). 991–995. 1 indexed citations
5.
Inker, Lesley A., Hocine Tighiouart, Michael G. Shlipak, et al.. (2023). CKD-EPI and EKFC GFR Estimating Equations: Performance and Other Considerations for Selecting Equations for Implementation in Adults. Journal of the American Society of Nephrology. 34(12). 1953–1964. 25 indexed citations
6.
Pottel, Hans, Ulf Nyman, Jonas Björk, et al.. (2023). Extending the cystatin C based EKFC-equation to children – validation results from Europe. Pediatric Nephrology. 39(4). 1177–1183. 4 indexed citations
7.
Pottel, Hans, Étienne Cavalier, Jonas Björk, et al.. (2022). Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function. Clinical Kidney Journal. 15(12). 2258–2265. 11 indexed citations
8.
Öberg, Carl M., Martin Lindström, Anders Grubb, & Anders Christensson. (2021). Potential relationship between eGFR cystatin C /eGFR creatinine ‐ratio and glomerular basement membrane thickness in diabetic kidney disease. Physiological Reports. 9(13). e14939–e14939. 22 indexed citations
9.
Björk, Jonas, Ulf Nyman, Ulla Berg, et al.. (2019). Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of children. Pediatric Nephrology. 34(6). 1087–1098. 40 indexed citations
10.
Björk, Jonas, Natalie Ebert, Marie Evans, et al.. (2017). GFR estimation based on standardized creatinine and cystatin C: a European multicenter analysis in older adults. Clinical Chemistry and Laboratory Medicine (CCLM). 56(3). 422–435. 32 indexed citations
11.
Szymańska, Aneta, et al.. (2008). The impact of human cystatin C hinge loop L1 on its dimerization and oligomerization propensity. PubMed Central. 14. 184–184. 1 indexed citations
12.
Wilson, Nicholas S., Katarina Håkansson, Raymond J. Steptoe, et al.. (2003). The Protease Inhibitor Cystatin C Is Differentially Expressed among Dendritic Cell Populations, but Does Not Control Antigen Presentation. The Journal of Immunology. 171(10). 5003–5011. 68 indexed citations
13.
Kasprzykowski, Franciszek, et al.. (2001). Peptidyl diazomethylketones as cysteine protease inhibitors structurally based upon the inhibitory centers of cystatins. Lund University Publications (Lund University). 1 indexed citations
14.
Grubb, Anders, et al.. (2001). Cystatin C inhibits osteoclast formation and activation via different mechanisms. Journal of Bone and Mineral Research. 16. 265–265. 1 indexed citations
15.
Bjarnadóttir, María, Carol L. Nilsson, Veronica Lindström, et al.. (2001). The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids. Amyloid. 8(1). 1–10. 37 indexed citations
16.
Grubb, Anders. (1994). Surrogate contract: parentage -- Johnson v. Calvert.. PubMed. 2(2). 239–44. 1 indexed citations
17.
Grubb, Anders & David Pearl. (1991). Discovering the identity of a blood donor.. PubMed. 141(6510). 897–9. 1 indexed citations
18.
Abrahamson, Magnus, et al.. (1989). An efficient E. coli expression system for human cystatin C: Production and characterization of the native and N-terminally Ala-Met-Glu-Ala-Glu-extended inhibitor. Lund University Publications (Lund University). 1 indexed citations
19.
Ólafsson, Ísleifur, Helge Löfberg, Magnus Abrahamson, & Anders Grubb. (1988). Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. Scandinavian Journal of Clinical and Laboratory Investigation. 48(6). 573–582. 64 indexed citations
20.
Christensen, Peer Brehm, et al.. (1979). Demonstration of the non-identity between the Fc receptor for human IgG from group A streptococci type 15 and M protein, peptidoglycan and the group specific carbohydrate.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 87C(3). 257–61. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyoshi Kurokawa Breakdown of academic impact, for papers by Jeffrey B. Kopp Breakdown of academic impact, for papers by Hirofumi Makino Breakdown of academic impact, for papers by Alberto Ortíz Breakdown of academic impact, for papers by Ariela Benigni Breakdown of academic impact, for papers by Kerstin Amann Breakdown of academic impact, for papers by Masaomi Nangaku Breakdown of academic impact, for papers by Harry van Goor Breakdown of academic impact, for papers by Marta Ruiz‐Ortega Breakdown of academic impact, for papers by Ton J. Rabelink
Rankless by CCL
2026